Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 33 - Medicinal preparations containing inorganic active ingredients
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
06/2003
06/12/2003CA2469223A1 Trioxane derivatives as antimalaria or anticancer compounds
06/12/2003CA2468996A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
06/12/2003CA2468839A1 Methods of treating cancer using an fpt inhibitor and anti neoplastic agents
06/12/2003CA2466570A1 Aminoacetonitrile derivatives and their use for controlling parasites
06/12/2003CA2414036A1 Zeolitic inhibition of bacilllus anthracis group and its toxins
06/11/2003EP1317926A1 Xenon inhalant for pain treatment
06/11/2003EP1317886A1 Use of micronised zeolites as filter material
06/11/2003EP1317276A2 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects
06/11/2003EP1317272A2 Composition for improving the cell protection comprising a lipophilic antioxidant an a hydrophilic antioxidant
06/11/2003EP1317261A1 Preparation for treating diseases of bone tissues
06/11/2003EP1156828B1 Combination therapy for lymphoproliferative diseases
06/11/2003EP0938325B1 Methods for sterilizing male mammals
06/11/2003EP0910382B1 Squalamine in combination with other anti-cancer agents for treating tumors
06/11/2003EP0876101B1 A composition for odontostomatological use in cleaning and disinfecting the root canals and viable dentine
06/11/2003EP0821586B1 A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers
06/11/2003EP0750511B1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
06/11/2003CN1423562A Perfusion liquid preparations for ophthalmic operations
06/11/2003CN1423528A Nutritional modules
06/11/2003CN1422650A Ointment for treating various skin diseases and preparation method thereof
06/11/2003CN1422628A Baixue-Genzhi-Changshoubao-Chinese medicine for treating leukemia and concurrently treating aplastic anemia
06/11/2003CN1111066C Musk plaster for bone-set
06/11/2003CN1111061C Medicine for treating throat diseases and its preparing process
06/11/2003CN1111058C Vesania-treating medicine
06/11/2003CN1111049C Medicine for curing angitis and its preparing method
06/11/2003CN1111048C Combined medicine for curing alopecia areata
06/11/2003CN1111041C Plaster for treating cancer and tumor
06/10/2003US6576666 First fatty acid compound that is a linoleic or linolenic compound and a second fatty acid that is a docosahexaenoic acid compound, an omega-3 or an omega-2 fatty acid or derivative
06/10/2003US6576634 Pharmaceutical or dietetic preparation for improvement of fertility and sperm quality
06/10/2003US6576267 Composition and method for treating the effects of diseases and maladies
06/10/2003CA2065572C Novel complex phosphorous lipid based dietetic compositions and their use in sleep disorders
06/05/2003WO2003046171A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof
06/05/2003WO2003046170A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof
06/05/2003WO2003045973A2 Peptides with growth inhibitory action
06/05/2003WO2003045404A2 Treatment and diagnosis of diseases associated with adverse levels of zinc, cadmium and calcium
06/05/2003WO2003045403A1 Method of treating halitosis
06/05/2003WO2003045366A1 Treatment of wounds and compositions employed
06/05/2003WO2003045334A2 Methods and compositions for ameliorating the undesirable effects of chemotherapy
06/05/2003WO2003045274A2 Thermopolymer composition and related methods
06/05/2003WO2002074275A3 Systems for delivering a cosmetic and/or therapeutic active to oral surfaces
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030104342 Use of ozone for the treatment of dental and oral conditions
06/05/2003US20030104091 Probiotic formulation and method for reduction of pathogenic bacteria
06/05/2003US20030104073 Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same
06/05/2003US20030104071 Cellulose ether, especially ethyl cellulose, extended release coating
06/05/2003US20030104070 Coated potassium chloride granules and tablets
06/05/2003US20030104043 Topical cream for alleviating spider veins
06/05/2003US20030104021 High electrolyte content W/O emulsions for treating irritated/sensitive skins
06/05/2003US20030104014 Method for the treatment of malignant and infectious chronic diseases
06/05/2003US20030103973 Method for reducing tumor growth with VEGF antagonists combined with radiation and chemotherapy
06/05/2003US20030103938 Pharmaceutical compositions for preventing or treating Th1 and Th2 cell related diseases by modulating the Th1/Th2 ratio
06/05/2003US20030103896 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents
06/05/2003US20030103888 Reacting zirconyl chloride and polyphosphate; absorption of ammonia; dialysis
06/05/2003CA2468511A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468424A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468390A1 Treatment of wounds and compositions employed
06/05/2003CA2468187A1 Peptides with growth inhibitory action
06/05/2003CA2468154A1 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues
06/04/2003EP1316530A1 Micronised zeolites for use as pharmaceutical agents
06/04/2003EP1316255A1 Use of micronized minerals as plant protection agent
06/04/2003EP1315755A1 Anti-angiogenic peptides
06/04/2003EP1315509A2 Treatment of drug resistant organisms with nitric oxide
06/04/2003EP1315505A2 Pharmaceutical compositions for headache, migraine, nausea and emesis
06/04/2003EP1315480A2 "slow release" pharmaceutical compositions comprising lithium carbonate
06/04/2003EP1218016A4 Composition and method for producing lubricating, germicide foam
06/04/2003EP1119347A4 Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide
06/04/2003EP1107751B1 Medicament containing platinum complex compounds and the use thereof
06/04/2003EP0910357B1 Down-regulation of dna repair to enhance sensitivity to p53-mediated suppression
06/04/2003CN1422157A Divided dose therapies with vascular damaging activity
06/04/2003CN1421230A Granulation promoting and pus drawing out ointment
06/04/2003CN1110315C Fracture-setting medicine and its preparing method
06/04/2003CN1110307C Medicine for curing tinea unguium
06/04/2003CN1110306C High-effect mycin powder injection
06/03/2003US6573052 Method of determining a chemotherapeutic regimen based on ERCCI expression
06/03/2003US6572898 Electrolyte gels for maintaining hydration and rehydration
06/03/2003US6572896 Administering a cobalt or gadolinium ion source; melanomas
06/03/2003US6572884 Parenteral Cisplatin emulsion
06/03/2003US6572842 Preparation for dental treatment
05/2003
05/30/2003WO2003044038A2 Biologically active complex
05/30/2003WO2003043673A1 Device having osteoinductive and osteoconductive properties
05/30/2003WO2003043656A1 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
05/30/2003WO2003043644A1 Ulcerative-colitis therapeutic agent containing iron salt as active ingredient
05/30/2003WO2003043617A1 Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof
05/30/2003WO2003043607A1 A pharmaceutical composition for controlled release of a beta-lactam antibiotic
05/30/2003WO2003043569A2 Trans-10, cis-12 conjugated linoleic acid isomer for the treatment of diseases
05/30/2003WO2003043537A1 Improvements in curing aids with tetrasilver tetroxide molecular crystal devices
05/30/2003WO2003028697A3 Liposome loading with metal ions
05/30/2003WO2003003976A3 Compositions for removing human cerumen
05/30/2003WO2002078718A3 Compositions, methods and apparatuses for singlet oxygen delivery
05/30/2003WO2002076499A3 Combination treatment of pancreatic cancer
05/30/2003WO2002066040A3 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
05/30/2003WO2001080823A3 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
05/30/2003CA2467926A1 Biologically active complex
05/29/2003US20030100942 Hydrogel for the therapeutic treatment of aneurysms
05/29/2003US20030100594 Carbonic anhydrase inhibitor
05/29/2003US20030100482 NMDA oxidizing agents for protecting neurons from injury
05/29/2003US20030099747 Thickened oil compositions of edible oil
05/29/2003US20030099727 Compositions and methods for reducing cytotoxicity and inhibiting angiogenesis
05/29/2003US20030099724 Compounds for prevention of diabetic retinopathy
05/29/2003US20030099723 Method for the prevention or treatment of hypomagnesemia in pediatric patients and in patients with g-tubes or ng-tubes
05/29/2003US20030099721 Method for improving morbid dermatitis by inhibiting activity of a plasminogen activator in the skin
1 ... 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 ... 563